These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39012594)

  • 1. Optimized Protocol for the Regulation of DNA Methylation and Gene Expression Using Modified dCas9-SunTag Platforms.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2024; 2842():155-165. PubMed ID: 39012594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Gene Expression Using dCas9-SunTag Platforms.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2023; 2577():189-195. PubMed ID: 36173574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions.
    Morita S; Noguchi H; Horii T; Nakabayashi K; Kimura M; Okamura K; Sakai A; Nakashima H; Hata K; Nakashima K; Hatada I
    Nat Biotechnol; 2016 Oct; 34(10):1060-1065. PubMed ID: 27571369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
    Nguyen TV; Lister R
    Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform.
    Morita S; Horii T; Kimura M; Hatada I
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for Allele-Specific Epigenome Editing Using CRISPR/dCas9.
    Rajaram N; Bashtrykov P; Jeltsch A
    Methods Mol Biol; 2024; 2842():179-192. PubMed ID: 39012596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system.
    Josipović G; Tadić V; Klasić M; Zanki V; Bečeheli I; Chung F; Ghantous A; Keser T; Madunić J; Bošković M; Lauc G; Herceg Z; Vojta A; Zoldoš V
    Nucleic Acids Res; 2019 Oct; 47(18):9637-9657. PubMed ID: 31410472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.
    Huang YH; Su J; Lei Y; Brunetti L; Gundry MC; Zhang X; Jeong M; Li W; Goodell MA
    Genome Biol; 2017 Sep; 18(1):176. PubMed ID: 28923089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific manipulation of Arabidopsis loci using CRISPR-Cas9 SunTag systems.
    Papikian A; Liu W; Gallego-Bartolomé J; Jacobsen SE
    Nat Commun; 2019 Feb; 10(1):729. PubMed ID: 30760722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9.
    Sapozhnikov DM; Szyf M
    Nat Commun; 2021 Sep; 12(1):5711. PubMed ID: 34588447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
    Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
    Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted DNA demethylation of the
    Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells.
    Wilk C; Effenberg L; Abberger H; Steenpass L; Hansen W; Zeschnigk M; Kirschning C; Buer J; Kehrmann J
    Cell Immunol; 2022 Jan; 371():104471. PubMed ID: 34954490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
    Song MK; Kim YS
    Methods Mol Biol; 2024; 2761():81-91. PubMed ID: 38427231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus-Specific and Stable DNA Demethylation at the
    Albrecht C; Rajaram N; Broche J; Bashtrykov P; Jeltsch A
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Targeted DNA Methylation with dCas9-Coupled DNMT3A-DNMT3L Methyltransferase.
    Bashtrykov P; Rajaram N; Jeltsch A
    Methods Mol Biol; 2023; 2577():177-188. PubMed ID: 36173573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for DNA Methylation Editing of Imprinted Loci and Assessment of the Effects.
    Sekita Y; Kimura T
    Methods Mol Biol; 2024; 2842():167-178. PubMed ID: 39012595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.